US Stock MarketDetailed Quotes

TMDX TransMedics

Watchlist
  • 64.260
  • -1.450-2.21%
Close Dec 13 16:00 ET
  • 64.100
  • -0.160-0.25%
Post 20:01 ET
2.16BMarket Cap69.10P/E (TTM)

TransMedics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
63.72%108.76M
117.87%114.31M
133.07%96.85M
158.53%241.62M
158.72%81.17M
158.65%66.43M
155.66%52.47M
161.68%41.55M
208.83%93.46M
224.52%31.38M
Operating revenue
63.72%108.76M
117.87%114.31M
133.07%96.85M
162.38%241.6M
170.55%81.15M
158.65%66.43M
155.66%52.47M
161.68%41.55M
193.39%92.08M
210.25%30M
Cost of revenue
85.95%47.92M
186.47%45.04M
188.46%36.89M
210.53%87.53M
211.56%33.25M
240.49%25.77M
154.80%15.72M
238.67%12.79M
209.65%28.19M
297.91%10.67M
Gross profit
49.64%60.85M
88.51%69.26M
108.45%59.96M
136.08%154.09M
131.48%47.92M
124.47%40.66M
156.03%36.74M
137.66%28.77M
208.48%65.27M
196.35%20.7M
Operating expense
-17.50%56.92M
50.75%56.75M
54.08%47.54M
89.04%182.82M
64.91%45.32M
191.63%69M
56.24%37.65M
43.69%30.86M
59.62%96.71M
50.06%27.48M
Selling and administrative expenses
39.16%42.66M
46.12%42.9M
44.74%36.16M
71.04%119.55M
59.07%34.56M
81.91%30.65M
68.90%29.36M
79.24%24.98M
82.58%69.9M
81.05%21.73M
-General and administrative expense
39.16%42.66M
46.12%42.9M
44.74%36.16M
71.04%119.55M
59.07%34.56M
81.91%30.65M
81.28%29.36M
79.24%24.98M
--69.9M
--21.73M
Research and development costs
-62.79%14.27M
67.15%13.86M
93.83%11.38M
135.97%63.27M
86.95%10.76M
463.22%38.34M
23.49%8.29M
-22.07%5.87M
20.21%26.81M
-8.84%5.76M
Operating profit
113.85%3.92M
1,480.57%12.51M
694.59%12.42M
8.62%-28.73M
138.40%2.6M
-411.09%-28.34M
90.70%-906K
77.70%-2.09M
20.27%-31.44M
40.16%-6.78M
Net non-operating interest income expense
-119.69%-317K
91.10%-223K
-229.79%-3.6M
-189.61%-10.79M
-1,062.36%-11.71M
304.57%1.61M
-157.72%-2.51M
-13.65%-1.09M
3.82%-3.73M
-2.97%-1.01M
Non-operating interest income
-36.54%3.3M
--3.4M
----
----
----
--5.2M
----
----
----
----
Non-operating interest expense
0.75%3.62M
44.63%3.62M
229.79%3.6M
189.61%10.79M
257.99%3.61M
356.16%3.59M
157.72%2.51M
13.65%1.09M
-3.82%3.73M
2.97%1.01M
Other net income (expense)
450.00%700K
-108.23%-200K
543.24%3.57M
1,382.14%12.85M
1,102.49%13.05M
81.41%-200K
410.08%2.43M
344.49%555K
-14.25%-1M
414.49%1.09M
Gain on sale of security
450.00%700K
---200K
----
----
----
---200K
----
----
----
----
Other non- operating income (expenses)
----
----
543.24%3.57M
1,382.14%12.85M
----
----
410.08%2.43M
344.49%555K
-14.25%-1M
414.49%1.09M
Income before tax
115.76%4.25M
1,340.10%12.15M
572.11%12.39M
26.25%-26.67M
157.65%3.86M
-263.56%-26.93M
91.48%-980K
75.13%-2.63M
18.14%-36.17M
47.03%-6.7M
Income tax
101.92%29K
-295.24%-41K
1,681.82%196K
-2,589.39%-1.64M
-984.21%-168K
-8,031.58%-1.51M
-4.55%21K
83.33%11K
83.33%66K
11.76%19K
Net income
116.58%4.22M
1,318.18%12.19M
562.71%12.2M
30.92%-25.03M
159.99%4.03M
-242.34%-25.42M
91.31%-1M
75.04%-2.64M
18.06%-36.23M
46.95%-6.72M
Net income continuous Operations
116.58%4.22M
1,318.18%12.19M
562.71%12.2M
30.92%-25.03M
159.99%4.03M
-242.34%-25.42M
91.31%-1M
75.04%-2.64M
18.06%-36.23M
46.95%-6.72M
Minority interest income
Net income attributable to the parent company
116.58%4.22M
1,318.18%12.19M
562.71%12.2M
30.92%-25.03M
159.99%4.03M
-242.34%-25.42M
91.31%-1M
75.04%-2.64M
18.06%-36.23M
46.95%-6.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
116.58%4.22M
1,318.18%12.19M
562.71%12.2M
30.92%-25.03M
159.99%4.03M
-242.34%-25.42M
91.31%-1M
75.04%-2.64M
18.06%-36.23M
46.95%-6.72M
Basic earnings per share
116.67%0.13
1,333.33%0.37
562.50%0.37
37.40%-0.77
157.14%0.12
-212.00%-0.78
92.68%-0.03
78.95%-0.08
23.13%-1.23
54.35%-0.21
Diluted earnings per share
115.38%0.12
1,266.67%0.35
537.50%0.35
37.40%-0.77
157.14%0.12
-212.00%-0.78
92.68%-0.03
78.95%-0.08
23.13%-1.23
54.35%-0.21
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 63.72%108.76M117.87%114.31M133.07%96.85M158.53%241.62M158.72%81.17M158.65%66.43M155.66%52.47M161.68%41.55M208.83%93.46M224.52%31.38M
Operating revenue 63.72%108.76M117.87%114.31M133.07%96.85M162.38%241.6M170.55%81.15M158.65%66.43M155.66%52.47M161.68%41.55M193.39%92.08M210.25%30M
Cost of revenue 85.95%47.92M186.47%45.04M188.46%36.89M210.53%87.53M211.56%33.25M240.49%25.77M154.80%15.72M238.67%12.79M209.65%28.19M297.91%10.67M
Gross profit 49.64%60.85M88.51%69.26M108.45%59.96M136.08%154.09M131.48%47.92M124.47%40.66M156.03%36.74M137.66%28.77M208.48%65.27M196.35%20.7M
Operating expense -17.50%56.92M50.75%56.75M54.08%47.54M89.04%182.82M64.91%45.32M191.63%69M56.24%37.65M43.69%30.86M59.62%96.71M50.06%27.48M
Selling and administrative expenses 39.16%42.66M46.12%42.9M44.74%36.16M71.04%119.55M59.07%34.56M81.91%30.65M68.90%29.36M79.24%24.98M82.58%69.9M81.05%21.73M
-General and administrative expense 39.16%42.66M46.12%42.9M44.74%36.16M71.04%119.55M59.07%34.56M81.91%30.65M81.28%29.36M79.24%24.98M--69.9M--21.73M
Research and development costs -62.79%14.27M67.15%13.86M93.83%11.38M135.97%63.27M86.95%10.76M463.22%38.34M23.49%8.29M-22.07%5.87M20.21%26.81M-8.84%5.76M
Operating profit 113.85%3.92M1,480.57%12.51M694.59%12.42M8.62%-28.73M138.40%2.6M-411.09%-28.34M90.70%-906K77.70%-2.09M20.27%-31.44M40.16%-6.78M
Net non-operating interest income expense -119.69%-317K91.10%-223K-229.79%-3.6M-189.61%-10.79M-1,062.36%-11.71M304.57%1.61M-157.72%-2.51M-13.65%-1.09M3.82%-3.73M-2.97%-1.01M
Non-operating interest income -36.54%3.3M--3.4M--------------5.2M----------------
Non-operating interest expense 0.75%3.62M44.63%3.62M229.79%3.6M189.61%10.79M257.99%3.61M356.16%3.59M157.72%2.51M13.65%1.09M-3.82%3.73M2.97%1.01M
Other net income (expense) 450.00%700K-108.23%-200K543.24%3.57M1,382.14%12.85M1,102.49%13.05M81.41%-200K410.08%2.43M344.49%555K-14.25%-1M414.49%1.09M
Gain on sale of security 450.00%700K---200K---------------200K----------------
Other non- operating income (expenses) --------543.24%3.57M1,382.14%12.85M--------410.08%2.43M344.49%555K-14.25%-1M414.49%1.09M
Income before tax 115.76%4.25M1,340.10%12.15M572.11%12.39M26.25%-26.67M157.65%3.86M-263.56%-26.93M91.48%-980K75.13%-2.63M18.14%-36.17M47.03%-6.7M
Income tax 101.92%29K-295.24%-41K1,681.82%196K-2,589.39%-1.64M-984.21%-168K-8,031.58%-1.51M-4.55%21K83.33%11K83.33%66K11.76%19K
Net income 116.58%4.22M1,318.18%12.19M562.71%12.2M30.92%-25.03M159.99%4.03M-242.34%-25.42M91.31%-1M75.04%-2.64M18.06%-36.23M46.95%-6.72M
Net income continuous Operations 116.58%4.22M1,318.18%12.19M562.71%12.2M30.92%-25.03M159.99%4.03M-242.34%-25.42M91.31%-1M75.04%-2.64M18.06%-36.23M46.95%-6.72M
Minority interest income
Net income attributable to the parent company 116.58%4.22M1,318.18%12.19M562.71%12.2M30.92%-25.03M159.99%4.03M-242.34%-25.42M91.31%-1M75.04%-2.64M18.06%-36.23M46.95%-6.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 116.58%4.22M1,318.18%12.19M562.71%12.2M30.92%-25.03M159.99%4.03M-242.34%-25.42M91.31%-1M75.04%-2.64M18.06%-36.23M46.95%-6.72M
Basic earnings per share 116.67%0.131,333.33%0.37562.50%0.3737.40%-0.77157.14%0.12-212.00%-0.7892.68%-0.0378.95%-0.0823.13%-1.2354.35%-0.21
Diluted earnings per share 115.38%0.121,266.67%0.35537.50%0.3537.40%-0.77157.14%0.12-212.00%-0.7892.68%-0.0378.95%-0.0823.13%-1.2354.35%-0.21
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List